Ancillary Study to Protocol 20060104

Amgen logo

Amgen

Status

Completed

Conditions

Rheumatoid Arthritis

Treatments

Procedure: Blood draw

Study type

Observational

Funder types

Industry

Identifiers

NCT00439894
20060364

Details and patient eligibility

About

Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signed informed Consent Meet all inclusion critieria outlined in Amgen Protocol 20060104

Exclusion criteria

  • Meet exclusion criteria outlined in Amgen Protocol 20060104

Trial design

50 participants in 1 patient group

blood draw
Description:
One time blood draw
Treatment:
Procedure: Blood draw

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems